Sanofi Inks Research Deal with Audion

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

Sanofi has formed a research collaboration with the biopharmaceutical company Audion Therapeutics  to develop treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach.

This two-year collaborative research will utilize technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, one of the world's largest basic research facilities dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr. Albert Edge, who has strong expertise in stem cells and inner ear biology.

Audion licensed Dr. Edge's technology from Mass Eye and Ear. Under the terms of the ag